Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03482479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03482479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
February 4, 2019
Completion date
December 31, 2025
Enrollment
60 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

churg-strauss syndrome (css), eosinophilic granulomatosis with polyangiitis (egpa), giant cell arteritis, granulomatosis with polyangiitis, microscopic polyangiitis, polyarteritis nodosa, takayasu arteritis